Elizabeth Mitchell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Elizabeth Mitchell has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Courtney Betts
OHSU
1 shared publication - Nathan D. Pennock
Department of Radiation Medicine, School of Medicine, Oregon Health & Science University, Portland, OR, USA
1 shared publication - Pepper Schedin
Oregon Health and Science University
1 shared publication - Qiuchen Guo
Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR 97239, USA
1 shared publication
Latest Publications
- Open Access
- 13 January 2017
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 6 (1) , 10
Mammary Gland Involution Provides a Unique Model to Study the TGF-β Cancer Paradox
Transforming Growth Factor-β (TGF-β) signaling in cancer has been termed the “TGF-β paradox”, acting as both a tumor suppresser and promoter. The complexity of TGF-β signaling within the tumor is context dependent, and greatly impacted by cellular crosstalk between TGF-β responsive cells in the microenvironment including adjacent epithelial, endothelial, mesenchymal, and hematopoietic cells. Here we utilize normal, weaning-induced mammary gland involution as a tissue microenvironment model to study the complexity of TGF-β function. This article reviews facets of mammary gland involution that are TGF-β regulated, namely mammary epithelial cell death, immune activation, and extracellular matrix remodeling. We outline how distinct cellular responses and crosstalk between cell types during physiologically normal mammary gland involution contribute to simultaneous tumor suppressive and promotional microenvironments. We also highlight alternatives to direct TGF-β blocking anti-cancer therapies with an emphasis on eliciting concerted microenvironmental-mediated tumor suppression.
- 13 January 2017
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 6 (1) , 10
Open AccessMammary Gland Involution Provides a Unique Model to Study the TGF-β Cancer Paradox
Transforming Growth Factor-β (TGF-β) signaling in cancer has been termed the “TGF-β paradox”, acting as both a tumor suppresser and promoter. The complexity of TGF-β signaling within the tumor is context dependent, and greatly impacted by cellular crosstalk between TGF-β responsive cells in the microenvironment including adjacent epithelial, endothelial, mesenchymal, and hematopoietic cells. Here we utilize normal, weaning-induced mammary gland involution as a tissue microenvironment model to study the complexity of TGF-β function. This article reviews facets of mammary gland involution that are TGF-β regulated, namely mammary epithelial cell death, immune activation, and extracellular matrix remodeling. We outline how distinct cellular responses and crosstalk between cell types during physiologically normal mammary gland involution contribute to simultaneous tumor suppressive and promotional microenvironments. We also highlight alternatives to direct TGF-β blocking anti-cancer therapies with an emphasis on eliciting concerted microenvironmental-mediated tumor suppression.